Pharma: Other News To Note
Tuesday, March 26, 2013
Actavis Inc., of Parsippany, N.J., reached a settlement agreement with AstraZeneca plc, of London, resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5-, 10-, 20- and 40-mg tablets, the generic version of Crestor tablets, as well as Actavis' rosuvastatin zinc alternate salt product.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.